Home
Issues
Health Partnerships
News & Publications
Influenza Vaccines
About Us
News & Publications
Print
Contact us
News & Publications
News Releases
Speeches
Publications
Web News & Events Archive
» 2009 Q1
» 2008 Q4
» 2008 Q3
» 2008 Q2
» 2008 Q1
» 2007 Q4
» 2007 Q3
» 2007 Q2
» 2007 Q1
» 2006 Q3 & Q4
Press Contacts
Source:
Any
IFPMA
IFPMA IVS
Industry Issue:
Any
Access to Quality Health Care
Corporate Social Responsibility
Counterfeit Medicines
Ethical Promotion
Health Care Systems
Intellectual Property & Patents
Pharmaceuticals & The Use of the Internet
Regulatory & Scientific Affairs
Research & Development
Trade
Date
Title
25 June 2009
Alicia Greenidge, outgoing IFPMA Director General, to launch New Platform
IFPMA
24 June 2009
IFPMA Announces Johnson & Johnson as New Member Company
IFPMA
11 June 2009
IFPMA Member Companies Ready for H1N1 Influenza Pandemic
IFPMA
19 May 2009
IFPMA Director General Michael D. Boyd’s Remarks at WHO-UN Meeting with Vaccine CEOs
IFPMA
12 May 2009
Health Partnerships Book: Growing Industry Support for Child & Maternal Health, and Chronic Diseases in Developing Countries
IFPMA
30 April 2009
IFPMA Leadership Transition
IFPMA
24 February 2009
Authoritative New Study Reveals Global Pandemic Influenza Vaccine Capacity
IFPMA
26 November 2008
Updated Industry Clinical Trials Transparency Position Requires Disclosure of All Exploratory Efficacy Trials
IFPMA
19 November 2008
IFPMA Health Partnerships Survey: Pharmaceutical Industry Contributes a Significant Part of Total Health Development Aid
IFPMA
19 November 2008
2008 Developing World Disease R&D Status Report shows Growing Industry Effort on “Most Neglected” Diseases
IFPMA
Items 1 - 10 of 119
1
2
3
4
5
6
7
8
9
10
11
12